Mohammad Al-Jundi

Also affiliated with National Institute of Diabetes and Digestive and Kidney Diseases

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma”.

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

Frontiers in Endocrinology(2021)10.3389/fendo.2020.587065

N/A

0.723DataRank · unranked

9 citations

Mohammad Al-Jundi, Jaydira Del Rivero, Abhishek Jha, Marianne Knue, Joy Zou +7 more

Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [177Lu]Lu-DOTA-TATE therapy

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1275813

N/A

0.440DataRank · unranked

11 citations

Mohammad Al-Jundi, Sungyoung Auh, Abhishek Jha, Joy Zou, Inna Shamis +12 more

The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis

Thyroid(2024)10.1089/thy.2023.0711

N/A

0DataRank · unranked

27 citations

Mohammad Al-Jundi, Peter Foerster, Stephanie Cardenas, Gisela Butera, Sungyoung Auh +3 more